GlassScriptPhysician profile
Hong Jun Yun
NPI 1396065884
$88,963.52
in general payments reported to CMS, 2019-2025
26 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,638 · 2020: $276 · 2021: $5,730 · 2022: $30K · 2023: $20K · 2024: $16K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $15K · Food and Beverage: $6,005 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,550.00 |
| Travel and Lodging | $14,661.53 |
| Food and Beverage | $6,004.96 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $72,228.10 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $4,280.12 | 2019-2020 | |
| Edwards Lifesciences Corporation | $3,455.75 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Cathworks, INC. | $3,146.32 | 2021-2023 | Ffrangio |
| Boston Scientific Corporation | $2,706.91 | 2019-2025 | General - Vascular Access, Rotapro, Synergy |
| Abbott Laboratories | $1,085.84 | 2021-2025 | Triclip, Cardiomems |
| W. L. Gore & Associates, INC. | $225.85 | 2019 | |
| Cardiva Medical, INC. | $224.60 | 2024-2025 | Savvywire, Optowire |
| Novartis Pharmaceuticals Corporation | $178.29 | 2019-2025 | |
| Shockwave Medical, INC | $176.11 | 2022 | |
| Cardiovascular Systems INC. | $175.46 | 2019-2023 | Diamondback Coronary |
| Pfizer INC. | $175.26 | 2022-2025 | |
| Jenavalve Technology, INC. | $162.44 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.18 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $96.41 | 2020-2025 | Farxiga |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $77.12 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $72.92 | 2020-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $55.94 | 2021-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $55.84 | 2021-2024 | Xarelto |
| Endotronix, INC. | $41.73 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Teleflex LLC | $41.04 | 2023-2025 | Guideliner, Manta |
| Kestra Medical Technology Services, INC. | $40.77 | 2023-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $40.61 | 2022 | |
| Amgen INC. | $31.88 | 2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $15.96 | 2022 | |
| Terumo Medical Corporation | $15.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Jun Yun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.